Multiply Labs raises $75M to automate pharma manufacturing with robots

Multiply Labs, a startup building robotic automation for drugmakers, has raised $75 million in Series B funding led by medical researcher Patrick Soon-Shiong, with AstraZeneca and Teradyne among the backers. The company says its robotic clusters can boost manufacturing throughput 100-fold while cutting cost per dose by 74%.

• $75M Series B led by Patrick Soon-Shiong
• AstraZeneca and robotics maker Teradyne among investors
• Robots mimic manual steps, avoiding new regulatory approval
• Company claims 100x throughput and 74% lower cost per dose